Mutant Prevention Concentrations of Levofloxacin Alone and in Combination with Azithromycin, Ceftazidime, Colistin (Polymyxin E), Meropenem, Piperacillin-Tazobactam, and Tobramycin against Pseudomonas aeruginosa

The mutant prevention concentrations (MPCs) of levofloxacin alone and in combination with ceftazidime, colistin (polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin were established against Pseudomonas aeruginosa. Antibiotic combinations using levofloxacin with any antibiotic with indiv...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zhanel, George G., Mayer, Matthew, Laing, Nancy, Adam, Heather J.
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: American Society for Microbiology 2006
Konular:
Susceptibility
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1479108/
https://ncbi.nlm.nih.gov/pubmed/16723591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01620-05
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1479108/
https://ncbi.nlm.nih.gov/pubmed/16723591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01620-05

Benzer Materyaller